Kuo MT - Search Results

1

BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma.

Li YY, Wu C, Chen SM, Shah SS, Wangpaichitr M, Feun LG, Kuo MT, Suarez M, Prince J, Savaraj N. Li YY, et al. Among authors: kuo mt. Oncotarget. 2016 Apr 5;7(14):17665-80. doi: 10.18632/oncotarget.6882. Oncotarget. 2016. PMID: 26771234 Free PMC article.

2

TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation.

You M, Savaraj N, Kuo MT, Wangpaichitr M, Varona-Santos J, Wu C, Nguyen DM, Feun L. You M, et al. Among authors: kuo mt. Mol Cell Biochem. 2013 Feb;374(1-2):181-90. doi: 10.1007/s11010-012-1518-1. Epub 2012 Nov 20. Mol Cell Biochem. 2013. PMID: 23180246 Free PMC article.

3

Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.

Wangpaichitr M, Wu C, Li YY, Nguyen DJM, Kandemir H, Shah S, Chen S, Feun LG, Prince JS, Kuo MT, Savaraj N. Wangpaichitr M, et al. Among authors: kuo mt. Oncotarget. 2017 Jul 25;8(30):49275-49292. doi: 10.18632/oncotarget.17568. Oncotarget. 2017. PMID: 28525376 Free PMC article.

4

Degradation of AMPK-α1 sensitizes BRAF inhibitor-resistant melanoma cells to arginine deprivation.

Li YY, Wu C, Shah SS, Chen SM, Wangpaichitr M, Kuo MT, Feun LG, Han X, Suarez M, Prince J, Savaraj N. Li YY, et al. Among authors: kuo mt. Mol Oncol. 2017 Dec;11(12):1806-1825. doi: 10.1002/1878-0261.12151. Epub 2017 Nov 16. Mol Oncol. 2017. PMID: 29094484 Free PMC article.

5

Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma.

Wu C, You M, Nguyen D, Wangpaichitr M, Li YY, Feun LG, Kuo MT, Savaraj N. Wu C, et al. Among authors: kuo mt. Int J Mol Sci. 2021 Jul 16;22(14):7628. doi: 10.3390/ijms22147628. Int J Mol Sci. 2021. PMID: 34299249 Free PMC article. Review.

6

Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4.

Tsai WB, Aiba I, Lee SY, Feun L, Savaraj N, Kuo MT. Tsai WB, et al. Among authors: kuo mt. Mol Cancer Ther. 2009 Dec;8(12):3223-33. doi: 10.1158/1535-7163.MCT-09-0794. Mol Cancer Ther. 2009. PMID: 19934275 Free PMC article.

7

Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.

Kuo MT, Savaraj N, Feun LG. Kuo MT, et al. Oncotarget. 2010 Aug;1(4):246-51. doi: 10.18632/oncotarget.135. Oncotarget. 2010. PMID: 21152246 Free PMC article. Review.

8

Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells.

Tsai WB, Aiba I, Long Y, Lin HK, Feun L, Savaraj N, Kuo MT. Tsai WB, et al. Among authors: kuo mt. Cancer Res. 2012 May 15;72(10):2622-33. doi: 10.1158/0008-5472.CAN-11-3605. Epub 2012 Mar 29. Cancer Res. 2012. PMID: 22461507 Free PMC article.

9

Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction.

Long Y, Tsai WB, Wangpaichitr M, Tsukamoto T, Savaraj N, Feun LG, Kuo MT. Long Y, et al. Among authors: kuo mt. Mol Cancer Ther. 2013 Nov;12(11):2581-90. doi: 10.1158/1535-7163.MCT-13-0302. Epub 2013 Aug 26. Mol Cancer Ther. 2013. PMID: 23979920 Free PMC article.

10

Arginine deprivation in cancer therapy.

Feun LG, Kuo MT, Savaraj N. Feun LG, et al. Among authors: kuo mt. Curr Opin Clin Nutr Metab Care. 2015 Jan;18(1):78-82. doi: 10.1097/MCO.0000000000000122. Curr Opin Clin Nutr Metab Care. 2015. PMID: 25474015 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters